Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All PPI studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchPPIsPPIs (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19

Ramachandran et al., European Journal of Gastroenterology & Hepatology, doi:10.1097/MEG.0000000000002013
Nov 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality -92% Improvement Relative Risk ARDS -80% PPIs for COVID-19  Ramachandran et al.  Prophylaxis Is prophylaxis with PPIs beneficial for COVID-19? Retrospective 295 patients in the USA (March - April 2020) Higher mortality (p=0.022) and progression (p=0.015) c19early.org Ramachandran et al., European J. Gastr.., Nov 2021 FavorsPPI Favorscontrol 0 0.5 1 1.5 2+
PPIs for COVID-19
1st treatment shown to increase risk in September 2020
 
*, now with p = 0.00000031 from 37 studies.
* From meta analysis with ≥3 studies.
4,700+ studies for 94 treatments. c19early.org
Retrospective 295 hospitalized COVID-19 patients showing higher mortality and acute respiratory distress syndrome (ARDS) with pre-hospitalization proton pump inhibitor (PPI) use. Authors hypothesize that hypochlorhydria caused by PPIs may allow SARS-CoV-2 to more easily infect the gastrointestinal tract.
risk of death, 92.0% higher, RR 1.92, p = 0.02, treatment 16 of 46 (34.8%), control 40 of 249 (16.1%), adjusted per study, odds ratio converted to relative risk, multivariable.
ARDS, 80.1% higher, RR 1.80, p = 0.01, treatment 18 of 46 (39.1%), control 55 of 249 (22.1%), adjusted per study, odds ratio converted to relative risk, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ramachandran et al., 30 Nov 2021, retrospective, USA, peer-reviewed, 7 authors, study period 1 March, 2020 - 25 April, 2020. Contact: doc.hemant@yahoo.com.
This PaperPPIsAll
Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19
Preethi Ramachandran, Abhilash Perisetti, Mahesh Gajendran, Farla Jean-Louis, Pardeep Bansal, Alok Kumar Dwivedi, MD, FACP Hemant Goyal
European Journal of Gastroenterology & Hepatology, doi:10.1097/meg.0000000000002013
Introduction Severe acute respiratory syndrome coronavirus-2 may escape the inactivation by gastric acid because of hypochlorhydria caused by proton pump inhibitors (PPIs), which could predispose the patients to severe COVID-19. Methods We studied the association between prehospitalization PPI exposure and clinical outcomes among hospitalized COVID-19 patients. Results A total of 295 hospitalized COVID-19 patients were included in the study. 15.6% of hospitalized COVID-19 patients were on PPIs at home. Mortality among PPI-users was 2.3 times higher than non-users, along with 2.3 times higher risk of acute respiratory distress syndrome after adjusting for confounding variables. Conclusion We found that prehospitalization PPI-exposure is independently associated with worse clinical outcomes, including mortality in COVID-19 patients, regardless of the presence of cardiovascular comorbidities.
Conflicts of interest There are no conflicts of interest.
References
Almario, Chey, Spiegel, Increased risk of COVID-19 among users of proton pump inhibitors, Am J Gastroenterol
Aloysius, Thatti, Gupta, Sharma, Bansal et al., COVID-19 presenting as acute pancreatitis, Pancreatology
Aziz, Perisetti, Smith, Gajendran, Bansal et al., Taste changes (dysgeusia) in COVID-19: a systematic review and meta-analysis, Gastroenterology
Boregowda, Aloysius, Perisetti, Gajendran, Bansal et al., Serum activity of liver enzymes is associated with higher mortality in COVID-19: a systematic review and meta-analysis, Front Med
Buendgens, Bruensing, Matthes, Dückers, Luedde et al., Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea, J Crit Care
Cheng, Zhu, Faden, Interactions of bile acids and the gut microbiota: learning from the differences in Clostridium difficile infection between children and adults, Physiol Genomics
Darnell, Subbarao, Feinstone, Taylor, Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV, J Virol Methods
Dhar, Mohanty, Gut microbiota and COVID-19-possible link and implications, Virus Res
Freedberg, Conigliaro, Wang, Tracey, Callahan et al., Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study, Gastroenterology
Gadiparthi, Perisetti, Sayana, Tharian, Inamdar et al., Gastrointestinal bleeding in patients with Severe SARS-CoV-2, Am J Gastroenterol
Goyal, Perisetti, Rehman, Singla, New and emerging therapies in treatment of Clostridium difficile infection, Eur J Gastroenterol Hepatol
Hamming, Timens, Bulthuis, Lely, Navis et al., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol
Jackson, Goodrich, Maxan, Freedberg, Abrams et al., Proton pump inhibitors alter the composition of the gut microbiota, Gut
Johnson, Harris, Cain, Hummer, Goyal et al., pulmonary and extra-pulmonary clinical manifestations of COVID-19, Front Med
Kopel, Perisetti, Gajendran, Boregowda, Goyal, Clinical insights into the gastrointestinal manifestations of COVID-19, Dig Dis Sci
Lee, Ha, Yeniova, Moon, Kim et al., Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching, Gut
Lombardo, Foti, Ruggia, Chiecchio, Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy, Clin Gastroenterol Hepatol
Luxenburger, Sturm, Biever, Rieg, Duerschmied et al., Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?, J Intern Med, doi:10.1111/joim.13121
Maclaren, Reynolds, Allen, Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit, JAMA Intern Med
Mather, Seip, Mckay, Impact of famotidine use on clinical outcomes of hospitalized patients with COVID-19, Am J Gastroenterol
Miller, Gastric acidity during the first year of life, Arch Dis Child
Pan, Mu, Yang, Sun, Wang et al., Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study, Am J Gastroenterol
Perisetti, Gajendran, Boregowda, Bansal, Goyal, COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies, Dig Endosc
Perisetti, Khan, Sahmoun, Newman, Meidinger, Role of Prophylactic Pre-Esophagogastroduodenoscopy (EGD) Endotracheal Intubation (ETI) in Upper Gastrointestinal Bleed (UGIB): a retrospective study: 42, Am J Gastroenterol
Price, Could the severity of COVID-19 be increased by low gastric acidity?, Crit Care
Ramachandran, Onukogu, Ghanta, Gajendran, Perisetti et al., Gastrointestinal symptoms and outcomes in hospitalized coronavirus disease 2019 patients, Dig Dis
Ranieri, Rubenfeld, Thompson, Ferguson, Acute respiratory distress syndrome: the Berlin definition, JAMA
Shin, Sachs, Pharmacology of proton pump inhibitors, Curr Gastroenterol Rep
Singh, Bilal, Pakhchanian, Raiker, Kochhar et al., Impact of obesity on outcomes of patients with COVID-19 in United States: a multicenter electronic health records network study, Gastroenterology
Wu, Liu, Yang, Zhang, Zhong et al., Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods, Acta Pharm Sin B
Xiao, Tang, Zheng, Liu, Li et al., Evidence for gastrointestinal infection of SARS-CoV-2, Gastroenterology
Xie, Bowe, Li, Xian, Yan et al., Risk of death among users of proton pump inhibitors: a longitudinal observational cohort study of United States veterans, BMJ Open
{ 'indexed': {'date-parts': [[2024, 7, 3]], 'date-time': '2024-07-03T07:16:13Z', 'timestamp': 1719990973022}, 'reference-count': 32, 'publisher': 'Ovid Technologies (Wolters Kluwer Health)', 'issue': '2', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2022, 2]]}, 'abstract': '<jats:sec>\n' ' <jats:title>Introduction</jats:title>\n' ' <jats:p>Severe acute respiratory syndrome coronavirus-2 may escape the ' 'inactivation by gastric acid because of hypochlorhydria caused by proton pump inhibitors ' '(PPIs), which could predispose the patients to severe COVID-19.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Methods</jats:title>\n' ' <jats:p>We studied the association between prehospitalization PPI exposure and ' 'clinical outcomes among hospitalized COVID-19 patients.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Results</jats:title>\n' ' <jats:p>A total of 295 hospitalized COVID-19 patients were included in the study. ' '15.6% of hospitalized COVID-19 patients were on PPIs at home. Mortality among PPI-users was ' '2.3 times higher than non-users, along with 2.3 times higher risk of acute respiratory ' 'distress syndrome after adjusting for confounding variables.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Conclusion</jats:title>\n' ' <jats:p>We found that prehospitalization PPI-exposure is independently associated ' 'with worse clinical outcomes, including mortality in COVID-19 patients, regardless of the ' 'presence of cardiovascular comorbidities.</jats:p>\n' ' </jats:sec>', 'DOI': '10.1097/meg.0000000000002013', 'type': 'journal-article', 'created': { 'date-parts': [[2020, 11, 29]], 'date-time': '2020-11-29T20:03:09Z', 'timestamp': 1606680189000}, 'page': '137-141', 'source': 'Crossref', 'is-referenced-by-count': 27, 'title': 'Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19', 'prefix': '10.1097', 'volume': '34', 'author': [ { 'given': 'Preethi', 'family': 'Ramachandran', 'sequence': 'first', 'affiliation': [{'name': 'Midamerica Cancer Care, West Kansas City, Missouri'}]}, { 'given': 'Abhilash', 'family': 'Perisetti', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Gastroenterology and Hepatology, University of ' 'Arkansas for Medical Sciences, Little Rock, Arkansas'}]}, { 'given': 'Mahesh', 'family': 'Gajendran', 'sequence': 'additional', 'affiliation': [ { 'name': 'Texas Tech University, Paul L Foster School of Medicine, El ' 'Paso, Texas'}]}, { 'given': 'Farla', 'family': 'Jean-Louis', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Internal Medicine, Brookdale University Hospital ' 'and Medical Center, Brooklyn, New York'}]}, { 'given': 'Pardeep', 'family': 'Bansal', 'sequence': 'additional', 'affiliation': [ { 'name': 'Division of Gastroenterology, Moses Taylor Hospital and Reginal ' 'Hospital of Scranton, Scranton, Pennsylvania'}]}, { 'given': 'Alok Kumar', 'family': 'Dwivedi', 'sequence': 'additional', 'affiliation': [ { 'name': 'Division of Biostatistics and Epidemiology, Department of ' 'Molecular and Translational Medicine, Texas Tech University, ' 'Paul L Foster School of Medicine, El Paso, Texas'}]}, { 'given': 'Hemant', 'family': 'Goyal', 'sequence': 'additional', 'affiliation': [ { 'name': 'The Wright Center for Graduate Medical Education, Scranton, ' 'Pennsylvania, USA'}]}], 'member': '276', 'published-online': {'date-parts': [[2021, 11, 30]]}, 'reference': [ { 'key': 'R1-20230916', 'doi-asserted-by': 'crossref', 'first-page': '1831', 'DOI': '10.1053/j.gastro.2020.02.055', 'article-title': 'Evidence for gastrointestinal infection of SARS-CoV-2', 'volume': '158', 'author': 'Xiao', 'year': '2020', 'journal-title': 'Gastroenterology'}, { 'key': 'R2-20230916', 'doi-asserted-by': 'crossref', 'first-page': '766', 'DOI': '10.14309/ajg.0000000000000620', 'article-title': 'Clinical characteristics of COVID-19 patients with digestive symptoms ' 'in Hubei, China: a descriptive, cross-sectional, multicenter study', 'volume': '115', 'author': 'Pan', 'year': '2020', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R3-20230916', 'doi-asserted-by': 'crossref', 'first-page': '715', 'DOI': '10.1111/den.13693', 'article-title': 'COVID-19 and gastrointestinal endoscopies: current insights and ' 'emergent strategies', 'volume': '32', 'author': 'Perisetti', 'year': '2020', 'journal-title': 'Dig Endosc'}, { 'key': 'R4-20230916', 'doi-asserted-by': 'crossref', 'first-page': '1132', 'DOI': '10.1053/j.gastro.2020.05.003', 'article-title': 'Taste changes (dysgeusia) in COVID-19: a systematic review and ' 'meta-analysis', 'volume': '159', 'author': 'Aziz', 'year': '2020', 'journal-title': 'Gastroenterology'}, { 'key': 'R5-20230916', 'doi-asserted-by': 'crossref', 'first-page': '526', 'DOI': '10.3389/fmed.2020.00526', 'article-title': 'pulmonary and extra-pulmonary clinical manifestations of COVID-19', 'volume': '7', 'author': 'Johnson', 'year': '2020', 'journal-title': 'Front Med (Lausanne)'}, { 'key': 'R6-20230916', 'doi-asserted-by': 'crossref', 'first-page': '1026', 'DOI': '10.1016/j.pan.2020.05.003', 'article-title': 'COVID-19 presenting as acute pancreatitis', 'volume': '20', 'author': 'Aloysius', 'year': '2020', 'journal-title': 'Pancreatology'}, { 'key': 'R7-20230916', 'doi-asserted-by': 'crossref', 'first-page': '1932', 'DOI': '10.1007/s10620-020-06362-8', 'article-title': 'Clinical insights into the gastrointestinal manifestations of COVID-19', 'volume': '65', 'author': 'Kopel', 'year': '2020', 'journal-title': 'Dig Dis Sci'}, { 'key': 'R8-20230916', 'doi-asserted-by': 'crossref', 'first-page': '1283', 'DOI': '10.14309/ajg.0000000000000719', 'article-title': 'Gastrointestinal bleeding in patients with Severe SARS-CoV-2', 'volume': '115', 'author': 'Gadiparthi', 'year': '2020', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R9-20230916', 'doi-asserted-by': 'crossref', 'first-page': '85', 'DOI': '10.1016/j.jviromet.2004.06.006', 'article-title': 'Inactivation of the coronavirus that induces severe acute respiratory ' 'syndrome, SARS-CoV', 'volume': '121', 'author': 'Darnell', 'year': '2004', 'journal-title': 'J Virol Methods'}, { 'key': 'R10-20230916', 'first-page': 'gutjnl-2020-322248', 'article-title': 'Severe clinical outcomes of COVID-19 associated with proton pump ' 'inhibitors: a nationwide cohort study with propensity score matching', 'author': 'Lee', 'year': '2020', 'journal-title': 'Gut'}, { 'key': 'R11-20230916', 'first-page': '10.1111/joim.13121', 'article-title': 'Treatment with proton pump inhibitors increases the risk of secondary ' 'infections and ARDS in hospitalized patients with COVID-19: coincidence ' 'or underestimated risk factor?', 'author': 'Luxenburger', 'year': '2020', 'journal-title': 'J Intern Med'}, { 'key': 'R12-20230916', 'doi-asserted-by': 'crossref', 'first-page': '198018', 'DOI': '10.1016/j.virusres.2020.198018', 'article-title': 'Gut microbiota and COVID-19- possible link and implications', 'volume': '285', 'author': 'Dhar', 'year': '2020', 'journal-title': 'Virus Res'}, { 'key': 'R13-20230916', 'first-page': '2526', 'article-title': 'Acute respiratory distress syndrome: the Berlin definition', 'volume': '307', 'author': 'Ranieri', 'year': '2012', 'journal-title': 'JAMA'}, { 'key': 'R14-20230916', 'doi-asserted-by': 'crossref', 'first-page': '528', 'DOI': '10.1007/s11894-008-0098-4', 'article-title': 'Pharmacology of proton pump inhibitors', 'volume': '10', 'author': 'Shin', 'year': '2008', 'journal-title': 'Curr Gastroenterol Rep'}, { 'key': 'R15-20230916', 'doi-asserted-by': 'crossref', 'first-page': '631', 'DOI': '10.1002/path.1570', 'article-title': 'Tissue distribution of ACE2 protein, the functional receptor for SARS ' 'coronavirus. A first step in understanding SARS pathogenesis', 'volume': '203', 'author': 'Hamming', 'year': '2004', 'journal-title': 'J Pathol'}, { 'key': 'R16-20230916', 'doi-asserted-by': 'crossref', 'first-page': '564', 'DOI': '10.1001/jamainternmed.2013.14673', 'article-title': 'Histamine-2 receptor antagonists vs proton pump inhibitors on ' 'gastrointestinal tract hemorrhage and infectious complications in the ' 'intensive care unit', 'volume': '174', 'author': 'MacLaren', 'year': '2014', 'journal-title': 'JAMA Intern Med'}, { 'key': 'R17-20230916', 'doi-asserted-by': 'crossref', 'first-page': '749', 'DOI': '10.1136/gutjnl-2015-310861', 'article-title': 'Proton pump inhibitors alter the composition of the gut microbiota', 'volume': '65', 'author': 'Jackson', 'year': '2016', 'journal-title': 'Gut'}, { 'key': 'R18-20230916', 'doi-asserted-by': 'crossref', 'first-page': '504', 'DOI': '10.1016/j.cgh.2009.12.022', 'article-title': 'Increased incidence of small intestinal bacterial overgrowth during ' 'proton pump inhibitor therapy', 'volume': '8', 'author': 'Lombardo', 'year': '2010', 'journal-title': 'Clin Gastroenterol Hepatol'}, { 'key': 'R19-20230916', 'doi-asserted-by': 'crossref', 'first-page': '696.e11', 'DOI': '10.1016/j.jcrc.2014.03.002', 'article-title': 'Administration of proton pump inhibitors in critically ill medical ' 'patients is associated with increased risk of developing Clostridium ' 'difficile-associated diarrhea', 'volume': '29', 'author': 'Buendgens', 'year': '2014', 'journal-title': 'J Crit Care'}, { 'issue': 'Supple 1', 'key': 'R20-20230916', 'doi-asserted-by': 'crossref', 'first-page': 'S15', 'DOI': '10.14309/00000434-201310001-00042', 'article-title': 'Role of Prophylactic Pre-Esophagogastroduodenoscopy (EGD) Endotracheal ' 'Intubation (ETI) in Upper Gastrointestinal Bleed (UGIB): a ' 'retrospective study: 42', 'volume': '108', 'author': 'Perisetti', 'year': '2013', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R21-20230916', 'doi-asserted-by': 'crossref', 'first-page': '589', 'DOI': '10.1097/MEG.0000000000001103', 'article-title': 'New and emerging therapies in treatment of Clostridium difficile ' 'infection', 'volume': '30', 'author': 'Goyal', 'year': '2018', 'journal-title': 'Eur J Gastroenterol Hepatol'}, { 'key': 'R22-20230916', 'doi-asserted-by': 'crossref', 'first-page': '373', 'DOI': '10.1159/000509774', 'article-title': 'Gastrointestinal symptoms and outcomes in hospitalized coronavirus ' 'disease 2019 patients', 'volume': '38', 'author': 'Ramachandran', 'year': '2020', 'journal-title': 'Dig Dis'}, { 'key': 'R23-20230916', 'doi-asserted-by': 'crossref', 'first-page': '431', 'DOI': '10.3389/fmed.2020.00431', 'article-title': 'Serum activity of liver enzymes is associated with higher mortality in ' 'COVID-19: a systematic review and meta-analysis', 'volume': '7', 'author': 'Boregowda', 'year': '2020', 'journal-title': 'Front Med (Lausanne)'}, { 'key': 'R24-20230916', 'doi-asserted-by': 'crossref', 'first-page': '1707', 'DOI': '10.14309/ajg.0000000000000798', 'article-title': 'Increased risk of COVID-19 among users of proton pump inhibitors', 'volume': '115', 'author': 'Almario', 'year': '2020', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R25-20230916', 'doi-asserted-by': 'crossref', 'first-page': '1617', 'DOI': '10.14309/ajg.0000000000000832', 'article-title': 'Impact of famotidine use on clinical outcomes of hospitalized patients ' 'with COVID-19', 'volume': '115', 'author': 'Mather', 'year': '2020', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R26-20230916', 'doi-asserted-by': 'crossref', 'first-page': '766', 'DOI': '10.1016/j.apsb.2020.02.008', 'article-title': 'Analysis of therapeutic targets for SARS-CoV-2 and discovery of ' 'potential drugs by computational methods', 'volume': '10', 'author': 'Wu', 'year': '2020', 'journal-title': 'Acta Pharm Sin B'}, { 'key': 'R27-20230916', 'doi-asserted-by': 'crossref', 'first-page': '1129', 'DOI': '10.1053/j.gastro.2020.05.053', 'article-title': 'Famotidine use is associated with improved clinical outcomes in ' 'hospitalized COVID-19 patients: a propensity score matched ' 'retrospective cohort study', 'volume': '159', 'author': 'Freedberg', 'year': '2020', 'journal-title': 'Gastroenterology'}, { 'key': 'R28-20230916', 'doi-asserted-by': 'crossref', 'first-page': '456', 'DOI': '10.1186/s13054-020-03182-0', 'article-title': 'Could the severity of COVID-19 be increased by low gastric acidity?', 'volume': '24', 'author': 'Price', 'year': '2020', 'journal-title': 'Crit Care'}, { 'key': 'R29-20230916', 'doi-asserted-by': 'crossref', 'first-page': '198', 'DOI': '10.1136/adc.17.92.198', 'article-title': 'Gastric acidity during the first year of life', 'volume': '17', 'author': 'Miller', 'year': '1942', 'journal-title': 'Arch Dis Child'}, { 'key': 'R30-20230916', 'doi-asserted-by': 'crossref', 'first-page': '218', 'DOI': '10.1152/physiolgenomics.00034.2019', 'article-title': 'Interactions of bile acids and the gut microbiota: learning from the ' 'differences in Clostridium difficile infection between children and ' 'adults', 'volume': '51', 'author': 'Cheng', 'year': '2019', 'journal-title': 'Physiol Genomics'}, { 'key': 'R31-20230916', 'first-page': 'S0016-5085(20)35067-35068', 'article-title': 'Impact of obesity on outcomes of patients with COVID-19 in United ' 'States: a multicenter electronic health records network study', 'author': 'Singh', 'year': '2020', 'journal-title': 'Gastroenterology'}, { 'key': 'R32-20230916', 'doi-asserted-by': 'crossref', 'first-page': 'e015735', 'DOI': '10.1136/bmjopen-2016-015735', 'article-title': 'Risk of death among users of proton pump inhibitors: a longitudinal ' 'observational cohort study of United States veterans', 'volume': '7', 'author': 'Xie', 'year': '2017', 'journal-title': 'BMJ Open'}], 'container-title': 'European Journal of Gastroenterology &amp; Hepatology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://journals.lww.com/10.1097/MEG.0000000000002013', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 9, 16]], 'date-time': '2023-09-16T16:13:22Z', 'timestamp': 1694880802000}, 'score': 1, 'resource': {'primary': {'URL': 'https://journals.lww.com/10.1097/MEG.0000000000002013'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 11, 30]]}, 'references-count': 32, 'journal-issue': {'issue': '2', 'published-print': {'date-parts': [[2022]]}}, 'URL': 'http://dx.doi.org/10.1097/MEG.0000000000002013', 'relation': { 'has-preprint': [ { 'id-type': 'doi', 'id': '10.1101/2020.07.12.20151084', 'asserted-by': 'object'}]}, 'ISSN': ['0954-691X'], 'subject': [], 'published': {'date-parts': [[2021, 11, 30]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit